PT Medikaloka Hermina TbkISX:HEAL -2.14%72 ROA % is 3.38% as of Mar. 2026, which is 27% below its 10-year median of 4.64. GuruFocus rates ISX:HEAL with a GF Score™ of 72/100 and a GF Value™ of Rp1,580.69 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, PT Medikaloka Hermina Tbk ranks better than 58.42% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. PT Medikaloka Hermina Tbk's annualizedNet Income for the quarter that ended in Mar. 2026 was Rp405,048 Mil.
PT Medikaloka Hermina Tbk's average Total Assets over the quarter that ended in Mar. 2026 was Rp11,983,113 Mil. Therefore, PT Medikaloka Hermina Tbk's annualized ROA % for the quarter that ended in Mar. 2026 was 3.38%.
The historical rank and industry rank for PT Medikaloka Hermina Tbk's ROA % or its related term are showing as below:
ISX:HEAL'
s ROA % Range Over the Past 10 Years
Min: 2.89 Med: 4.64 Max: 14.32
Current: 3.47
During the past 11 years, PT Medikaloka Hermina Tbk's highest ROA % was 14.32%. The lowest was 2.89%. And the median was 4.64%.
ISX:HEAL's ROA % is ranked better than 58.42% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.77
vs ISX:HEAL: 3.47
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's ROA % distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a ROA % of 3.38% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PT Medikaloka Hermina Tbk and its competitors. This is 27% below median its historical median of 4.64. Over the past decade, PT Medikaloka Hermina Tbk's ROA % has ranged from 2.89 to 14.32. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #284 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 41.6%.
Is PT Medikaloka Hermina Tbk's ROA % too high?
PT Medikaloka Hermina Tbk's current ROA % of 3.38% is 27% below median its 10-year median of 4.64. Over the past 10 years, this metric has ranged from a low of 2.89 to a high of 14.32. The Healthcare Providers & Services industry median ROA % is 1.77. PT Medikaloka Hermina Tbk's value of 3.38% is 91% above this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #284 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #284 out of 683 companies for ROA %. This puts PT Medikaloka Hermina Tbk in the upper half of its industry. The industry median ROA % is 1.77. PT Medikaloka Hermina Tbk's value of 3.38% is 91% above this benchmark. Historically, PT Medikaloka Hermina Tbk's own ROA % has ranged from 2.89 to 14.32 over the past decade. While the company's 10-year median is 4.64 vs. the industry median of 1.77, PT Medikaloka Hermina Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.77, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current ROA % of 3.38% is 91% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current ROA % is 3.38%, which is 27% below median its own 10-year median of 4.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,580.69, compared to a current price of Rp915.00 — trading 42.1% below its estimated fair value. The current ROA % is 3.38%, which is 27% below median its 10-year median of 4.64 and 91% above the Healthcare Providers & Services industry median of 1.77. PT Medikaloka Hermina Tbk's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current ROA % is 3.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp915.00 is trading 42.1% below its estimated GF Value™ of Rp1,580.69.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
ROA %: 3.38% (27% below median its 10-year median of 4.64)
GF Value™: Rp1,580.69 vs. price of Rp915.00 (42.1% below fair value)
Industry Position: 91% above the Healthcare Providers & Services median (#284 of 683)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
72GF Score
Get the complete analysis for ISX:HEAL
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
